Dr. Lance G Leithauser, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 9715 Medical Center Dr, 535, Rockville, MD 20850 Phone: 301-294-9400 Fax: 301-294-0149 |
Dr. Frederick Harvey Watkins Iv, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3203 Tower Oaks Blvd, #200, Rockville, MD 20852 Phone: 301-656-6398 Fax: 301-754-2503 |
Dr. Gregory O Dick, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 9711 Medical Center Dr Ste 100, Rockville, MD 20850 Phone: 301-251-2600 Fax: 301-251-2657 |
Dr. Adam G Tattelbaum, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3203 Tower Oaks Blvd, #200, Rockville, MD 20852 Phone: 301-656-6398 |
Nadya Andrea Clarke, Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9601 Blackwell Rd Ste 260, Rockville, MD 20850 Phone: 301-500-0215 |
Sung W Yoon, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 9715 Medical Center Dr, Suite 233, Rockville, MD 20850 Phone: 301-913-0304 Fax: 301-913-0306 |
Mackenzie Paige Moler, Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6120 Executive Blvd Ste 250, Rockville, MD 20852 Phone: 301-468-5991 |
Michael Paul Vincent, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15245 Shady Grove Rd, Suite 155, Rockville, MD 20850 Phone: 240-912-4708 Fax: 240-912-6992 |
Dr. Brent Cabell Faulkner, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 15245 Shady Grove Rd, Suite 155, Rockville, MD 20850 Phone: 240-912-4708 Fax: 240-912-6992 |
Dr. Robert B Karp, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 11119 Rockville Pike, Suite G100, Rockville, MD 20852 Phone: 301-770-6161 Fax: 301-984-3701 |
Dr. Janette Alexander, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 15005 Shady Grove Rd, #220, Rockville, MD 20850 Phone: 301-251-1184 Fax: 301-251-1185 |
News Archive
The COVID-19 pandemic is threatening three decades of improvement in health and social services for women, newborns, children and adolescents.
If critics really want to go back to the days when insurance companies ran wild with no accountability, they should have the courage to say so openly instead of hiding behind distracting attacks. In the meantime, we're going to keep standing up for American families and small business owners who deserve a system that works for them (Health and Human Services Secretary Kathleen Sebelius, 9/28).
Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted approval of the Company's Abbreviated New Drug Application for the generic version of Dilaudid-HP® 10mg/ml Injection. The company intends to begin shipping the product next month.
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
› Verified 6 days ago